Press Releases

Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO in Newly Diagnosed Multiple Myeloma

Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLAROâ„¢ (ixazomib) to lenalidomide and dexamethasone versus lenalidomide and dexamethasone plus placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem...

Tjoapack invests in automated injectables packaging capabilities

Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials. The automated packaging line for vials will start operations in Q1 2021 and will increase its capacity to over 12 million vials...

Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists

Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back following suspension in March and April 2020. Phesi’s previous analysis in May 2020 found that...

Aigenpulse launches data analysis suite to automate flow cytometry

Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes. With it, users will...

Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis

Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. The facility is adjacent to the company's biologics manufacturing facility, which recently doubled production capacity with...

GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise

Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced a partnership with GC Pharma, a South Korean biopharmaceutical company formerly known as Green Cross Corporation, to discover and develop novel hemophilia therapies. GC Pharma...

Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services

Co-Diagnostics Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that it has entered into an agreement with Arches Research, Inc, a CLIA laboratory and subsidiary of Polarity TE, Inc, to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read